The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel

BOLT Insider Trading (Bolt Biotherapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $11,054,000.00
Insider Selling (Last 12 Months): $0.00

Bolt Biotherapeutics Insider Trading History Chart

Bolt Biotherapeutics Share Price & Price History

$23.19
▼ -0.47 (-1.99%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
#1 trading secret
He started as a janitor’s grandson… and ended up becoming a million dollar hedge fund insider... Now he’s revealing the #1 trading secret he learned during his time on Wall Street…
Continue Reading
pixel

Bolt Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2021Edgar EnglemanDirectorBuy200,000$20.00$4,000,000.00
2/9/2021Randall C SchatzmanCEOBuy1,500$20.00$30,000.00
2/9/2021Vivo Capital Fund Viii, L.P.Major ShareholderBuy350,000$20.00$7,000,000.00  
2/9/2021William P QuinnCFOBuy1,200$20.00$24,000.00
See Full Table
Bolt Biotherapeutics logo
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Read More

Today's Range

Now: $23.19
$22.59
$24.97

50 Day Range

MA: $31.77
$23.66
$39.93

52 Week Range

Now: $23.19
$22.59
$43.07

Volume

119,387 shs

Average Volume

327,172 shs

Market Capitalization

$842.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bolt Biotherapeutics?

Bolt Biotherapeutics' top insider investors include:
  1. Edgar Engleman (Director)
  2. Randall C Schatzman (CEO)
  3. Vivo Capital Fund Viii, LP (Major Shareholder)
  4. William P Quinn (CFO)
The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel